Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB

Metformin reduces oxandrolone- induced depression-like behavior in rats via modulating the expression of IL-1β, IL-6, IL-10 and TNF-α

(2021) Alaa M. Hammad et al.   BEHAVIOURAL BRAIN RESEARCH

Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS–AMPK–mTORC1–autophagy pathway

(2020) Yang Yang et al.   Redox Biology

The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond

(2020) Hung-Yu Lin et al.   Cells

M1 macrophage mediated increased reactive oxygen species (ROS) influence wound healing via the MAPK signaling in vitro and in vivo

(2019) Zheng Deng et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

SAT-343-Alagebrium ameliorates NAFLD progression in mice fed a high advanced glycation end products diet via direct inhibition of Kupffer cells and indirect inhibition of hepatic stellate cell activation

(2019) Hettya Kandage Dinali Helan Fernando et al.   JOURNAL OF HEPATOLOGY

Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition

(2019) Yujia Yuan et al.   CLINICAL SCIENCE

Nicotinamide riboside exerts protective effect against aging-induced NAFLD-like hepatic dysfunction in mice

(2019) Xue Han et al.   PeerJ

The Potential of the FSP1cre-Pparb/d−/− Mouse Model for Studying Juvenile NAFLD

(2019) Chen et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Cadmium induced ROS alters M1 and M3 receptors, leading to SN56 cholinergic neuronal loss, through AChE variants disruption

(2018) Paula Moyano et al.   TOXICOLOGY

Saxagliptin regulates M1/M2 macrophage polarization via CaMKKβ/AMPK pathway to attenuate NAFLD

(2018) Yang Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications

(2017) Anna Alisi et al.   MEDIATORS OF INFLAMMATION

Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade

(2016) Zhengle Zhang et al.   CANCER LETTERS

Chronic NOS inhibition accelerates NAFLD progression in an obese rat model

(2015) Ryan D. Sheldon et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Tu2046 Early Compensatory Mechanism of the Liver After the Initial Accumulation of Fat in a Diet-Induced NAFLD Model

(2015) Sara K. Smith et al.   GASTROENTEROLOGY

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features

(2015) Luisa Vonghia et al.   PLoS One

Lactobacillus brevisG-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages

(2013) S.-E. Jang et al.   JOURNAL OF APPLIED MICROBIOLOGY

Oridonin: targeting programmed cell death pathways as an anti-tumour agent

(2012) Z. Liu et al.   CELL PROLIFERATION

The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: Synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents

(2012) Lei Wang et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Inflammatory responses of RAW 264.7 macrophages upon exposure to nanoparticles: Role of ROS-NFκB signaling pathway

(2011) Reddy P. Nishanth et al.   Nanotoxicology

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

(2008) Elizabeth M. Brunt et al.   HEPATOLOGY